Efficacy and Safety of a Purified Standardised Wasp Venom Preparation

Phase 3

Completed

• Conditions: Allergy

• Registration Number: NCT00263926
• Lead Sponsor: Allergopharma GmbH & Co. KG

Brief Summary

The trial is performed to assess efficacy and safety of a purified standardised wasp venom preparation in wasp venom allergy

Detailed Description

Not available

Study Timeline

• Study Start: 2001-03
• Study First Submitted: 2005-12-09
• Study First Submitted QC: 2005-12-09
• Study First Posted: 2005-12-12
• Primary Completion: 2007-05
• Study Completion: 2010-11
• Status Verified: 2013-03
• Last Update Submitted: 2013-03-08
• Last Update Posted: 2013-03-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• History of wasp venom allergy,
• Positive RAST to wasp venom,
• Positive skin prick test to wasp venom

Exclusion Criteria

• Serious chronic diseases

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Trial Locations

Locations (1)

Allergopharma GmbH & Co. KG; 🇩🇪 Reinbek, Germany